# Hippo Holdings Inc.: financial statements, quarterly

HIPO · NYSE · CIK 1828105 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hipo.md) · [Financials](/companies/hipo/financials.md) · [Filings](/companies/hipo/filings.md) · [Insiders](/companies/hipo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hipo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [57.7](/filings/0001828105-24-000056.md) | [64.5 d](/filings/0001828105-26-000008.md) | [85.1](/filings/0001828105-25-000036.md) | [89.6](/filings/0001828105-25-000055.md) | [95.5](/filings/0001828105-25-000070.md) | [102 d](/filings/0001828105-26-000008.md) | [110](/filings/0001828105-26-000025.md) | [117](/filings/0001828105-26-000043.md) | [121](/filings/0001828105-25-000070.md) | [120 d](/filings/0001828105-26-000008.md) | [122](/filings/0001828105-26-000025.md) | [145](/filings/0001828105-26-000043.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.3)](/filings/0001828105-24-000056.md) | [0.3 d](/filings/0001828105-26-000008.md) | [0.2](/filings/0001828105-25-000036.md) | [0.7](/filings/0001828105-25-000055.md) | [0.0](/filings/0001828105-25-000070.md) | [0.2 d](/filings/0001828105-26-000008.md) | [(0.2)](/filings/0001828105-26-000025.md) | [0.1](/filings/0001828105-26-000043.md) | [0.0](/filings/0001828105-25-000070.md) | [0.8 d](/filings/0001828105-26-000008.md) | [0.1](/filings/0001828105-26-000025.md) | [0.9](/filings/0001828105-26-000043.md) |
| Net income | $m | [(53.1)](/filings/0001828105-24-000056.md) | [(42.3) d](/filings/0001828105-26-000008.md) | [(35.7)](/filings/0001828105-25-000036.md) | [(40.5)](/filings/0001828105-25-000055.md) | [(8.5)](/filings/0001828105-25-000070.md) | [44.2 d](/filings/0001828105-26-000008.md) | [(47.7)](/filings/0001828105-26-000025.md) | [1.3](/filings/0001828105-26-000043.md) | [98.1](/filings/0001828105-25-000070.md) | [6.0 d](/filings/0001828105-26-000008.md) | [7.1](/filings/0001828105-26-000025.md) | [10.1](/filings/0001828105-26-000043.md) |
| Diluted EPS | $ per share | [(2.24)](/filings/0001828105-24-000056.md) | not reported | [(1.47)](/filings/0001828105-25-000036.md) | [(1.64)](/filings/0001828105-25-000055.md) | [(0.34)](/filings/0001828105-25-000070.md) | not reported | [(1.91)](/filings/0001828105-26-000025.md) | [0.05](/filings/0001828105-26-000043.md) | [3.77](/filings/0001828105-25-000070.md) | not reported | [0.27](/filings/0001828105-26-000025.md) | [0.38](/filings/0001828105-26-000043.md) |
| Basic EPS | $ per share | [(2.24)](/filings/0001828105-24-000056.md) | not reported | [(1.47)](/filings/0001828105-25-000036.md) | [(1.64)](/filings/0001828105-25-000055.md) | [(0.34)](/filings/0001828105-25-000070.md) | not reported | [(1.91)](/filings/0001828105-26-000025.md) | [0.05](/filings/0001828105-26-000043.md) | [3.90](/filings/0001828105-25-000070.md) | not reported | [0.27](/filings/0001828105-26-000025.md) | [0.38](/filings/0001828105-26-000043.md) |

- Revenue: us-gaap:Revenues
- Operating income: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [228](/filings/0001828105-23-000083.md) | [142](/filings/0001828105-25-000013.md) | [223](/filings/0001828105-24-000027.md) | [176](/filings/0001828105-24-000036.md) | [191](/filings/0001828105-24-000056.md) | [198](/filings/0001828105-26-000008.md) | [141](/filings/0001828105-25-000036.md) | [199](/filings/0001828105-25-000055.md) | [248](/filings/0001828105-25-000070.md) | [218](/filings/0001828105-26-000043.md) | [275](/filings/0001828105-26-000025.md) | [245](/filings/0001828105-26-000043.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,647](/filings/0001828105-23-000083.md) | [1,525](/filings/0001828105-25-000013.md) | [1,496](/filings/0001828105-24-000027.md) | [1,510](/filings/0001828105-24-000036.md) | [1,545](/filings/0001828105-24-000056.md) | [1,543](/filings/0001828105-26-000008.md) | [1,540](/filings/0001828105-25-000036.md) | [1,706](/filings/0001828105-25-000055.md) | [1,874](/filings/0001828105-25-000070.md) | [1,906](/filings/0001828105-26-000043.md) | [2,062](/filings/0001828105-26-000025.md) | [2,319](/filings/0001828105-26-000043.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [1,236](/filings/0001828105-23-000083.md) | [1,140](/filings/0001828105-25-000013.md) | [1,142](/filings/0001828105-24-000027.md) | [1,184](/filings/0001828105-24-000036.md) | [1,215](/filings/0001828105-24-000056.md) | [1,178](/filings/0001828105-26-000008.md) | [1,215](/filings/0001828105-25-000036.md) | [1,372](/filings/0001828105-25-000055.md) | [1,452](/filings/0001828105-25-000070.md) | [1,469](/filings/0001828105-26-000043.md) | [1,613](/filings/0001828105-26-000025.md) | [1,853](/filings/0001828105-26-000043.md) |
| Shareholders' equity | $m | [407](/filings/0001828105-23-000083.md) | [378](/filings/0001828105-25-000013.md) | [351](/filings/0001828105-24-000027.md) | [323](/filings/0001828105-24-000036.md) | [326](/filings/0001828105-24-000056.md) | [362](/filings/0001828105-26-000008.md) | [323](/filings/0001828105-25-000036.md) | [333](/filings/0001828105-25-000055.md) | [422](/filings/0001828105-25-000070.md) | [436](/filings/0001828105-26-000008.md) | [449](/filings/0001828105-26-000043.md) | [466](/filings/0001828105-26-000043.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.1 d](/filings/0001828105-24-000056.md) | [(48.5) d](/filings/0001828105-26-000008.md) | [17.7](/filings/0001828105-25-000036.md) | [(10.6) d](/filings/0001828105-25-000055.md) | [46.8 d](/filings/0001828105-25-000070.md) | [(6.4) d](/filings/0001828105-26-000008.md) | [(35.6)](/filings/0001828105-26-000025.md) | [24.7 d](/filings/0001828105-26-000043.md) | [16.9 d](/filings/0001828105-25-000070.md) | [3.2 d](/filings/0001828105-26-000008.md) | [8.5](/filings/0001828105-26-000025.md) | [43.1 d](/filings/0001828105-26-000043.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001828105-24-000056.md) | [0.4 d](/filings/0001828105-26-000008.md) | [0.1](/filings/0001828105-25-000036.md) | [0.1 d](/filings/0001828105-25-000055.md) | [0.0 d](/filings/0001828105-25-000070.md) | [0.1 d](/filings/0001828105-26-000008.md) | [0.1](/filings/0001828105-26-000025.md) | [(0.1) d](/filings/0001828105-26-000043.md) | [0.1 d](/filings/0001828105-25-000070.md) | [0.0 d](/filings/0001828105-26-000008.md) | [0.1](/filings/0001828105-26-000025.md) | [0.1 d](/filings/0001828105-26-000043.md) |
| Share repurchases | $m | [0.0 d](/filings/0001828105-24-000056.md) | [0.0 d](/filings/0001828105-26-000008.md) | [0.0](/filings/0001828105-24-000027.md) | [0.0 d](/filings/0001828105-24-000036.md) | [0.0 d](/filings/0001828105-25-000070.md) | [15.6 d](/filings/0001828105-26-000008.md) | not reported | not reported | not reported | [0.0 d](/filings/0001828105-26-000008.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.8](/filings/0001828105-23-000083.md) | [23.2](/filings/0001828105-24-000027.md) | [23.4](/filings/0001828105-24-000036.md) | [23.7](/filings/0001828105-24-000056.md) | [24.2](/filings/0001828105-25-000036.md) | [24.6](/filings/0001828105-25-000055.md) | [25.1](/filings/0001828105-25-000070.md) | [25.0](/filings/0001828105-26-000025.md) | [26.0](/filings/0001828105-26-000043.md) | [26.0](/filings/0001828105-25-000070.md) | [26.4](/filings/0001828105-26-000025.md) | [26.6](/filings/0001828105-26-000043.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 26,389,381 at 2026-07-24, from the cover of the [10-Q filed 2026-07-30](/filings/0001828105-26-000043.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.